Effect of Meal Composition and Timing on Evobrutinib Bioavailability
Clinical trial NCT03934502 · COMPLETED
Trial details
- NCT number
- NCT03934502
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-15
- Primary completion
- 2019-06-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.